TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 DEFINITION 21 2.2 SCOPE OF THE STUDY 21 2.3 RESEARCH OBJECTIVE 21 2.4 MARKET STRUCTURE 22 2.5 ASSUMPTIONS & LIMITATIONS 23 3 RESEARCH METHODOLOGY 3.1 DATA MINING 24 3.2 SECONDARY RESEARCH 25 3.3 PRIMARY RESEARCH 26 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 27 3.5 FORECASTING TECHNIQUES 28 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 29 3.6.1 BOTTOM-UP APPROACH 30 3.6.2 TOP-DOWN APPROACH 30 3.7 DATA TRIANGULATION 31 3.8 VALIDATION 31 4 MARKET DYNAMICS 4.1 OVERVIEW 32 4.2 DRIVERS 33 4.2.1 TECHNOLOGICAL DEVELOPMENTS AND GROUND-BREAKING TECHNIQUES 33 4.2.2 INCREASE IN DRUGS SHORTAGE COMPRISING CANCER MEDICINES 34 4.2.3 RISE IN AWARENESS AND ADAPTATION OF NEW TECHNOLOGIES AMONG CANCER HOSPITALS 34 4.2.4 RISING PREVALENCE OF CANCER PATIENTS 34 4.3 RESTRAINTS 36 4.3.1 DEARTH OF PRACTICED PHARMACISTS AND LAB TECHNICIANS 36 4.4 OPPORTUNITIES 36 4.4.1 NEW PRODUCT INNOVATIONS 36 4.4.2 RISE IN PARTNERSHIPS & COLLABORATIONS 36 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 37 5.1.1 R&D AND DESIGNING 37 5.1.2 MANUFACTURING 38 5.1.3 DISTRIBUTION & SALES 38 5.1.4 POST SALES SERVICES 38 5.2 PORTER’S FIVE FORCES MODEL 38 5.2.1 BARGAINING POWER OF SUPPLIERS 39 5.2.2 BARGAINING POWER OF BUYERS 39 5.2.3 THREAT OF NEW ENTRANTS 39 5.2.4 THREAT OF SUBSTITUTES 40 5.2.5 INTENSITY OF RIVALRY 40 5.3 COVID-19 IMPACT ANALYSIS 40 5.3.1 IMPACT ON SUPPLY CHAIN 41 5.3.2 IMPACT ON PRODUCTION 41 5.3.3 IMPACT ON REGIONS 41 5.3.4 DEMAND-SUPPLY GAP ANALYSIS 41 5.4 LIST OF POTENTIAL CUSTOMERS 42 6 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE 6.1 OVERVIEW 45 6.2 CHEMOTHERAPEUTIC 46 6.3 NON-CHEMOTHERAPEUTICS 46 7 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE 7.1 OVERVIEW 47 7.2 PHARMACEUTICAL INGREDIENT ALTERATION (PIA) 48 7.3 CURRENTLY UNAVAILABLE PHARMACEUTICAL MANUFACTURING (CUPM) 49 7.4 PHARMACEUTICAL DOSAGE ALTERATION (PDA) 50 8 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD 8.1 OVERVIEW 51 8.2 GRAVIMETRIC AUTOMATED COMPOUNDING DEVICE (WEIGHT-BASED) 52 8.3 VOLUMETRIC AUTOMATED COMPOUNDING DEVICE (VOLUME-BASED) 53 9 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY 9.1 OVERVIEW 54 9.2 STERILE 55 9.3 NON-STERILE 56 10 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY 10.1 OVERVIEW 57 10.2 WITH ROBOTIC ARMS 58 10.3 WITHOUT ROBOTIC ARMS 59 11 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE 11.1 OVERVIEW 60 11.2 PHARMODUCT 61 11.3 EQUASHIELD PRO 61 11.4 MEDIMIX 61 11.5 INTEGRA 61 11.6 OTHERS 61 12 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION 12.1 OVERVIEW 62 12.2 BREAST CANCER 63 12.3 BLOOD CANCER 64 12.4 PROSTATE CANCER 65 12.5 GASTROINTESTINAL CANCER 66 12.6 RESPIRATORY/LUNG CANCER 66 12.7 OTHERS 67 13 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY REGION 13.1 OVERVIEW 68 13.2 AMERICAS 69 13.2.1 NORTH AMERICA 73 13.2.1.1 US 76 13.2.1.2 CANADA 79 13.2.2 LATIN AMERICA 82 13.2.2.1 BRAZIL 85 13.2.2.2 REST OF LATIN AMERICA 88 13.3 EUROPE 92 13.3.1 WESTERN EUROPE 96 13.3.1.1 GERMANY 99 13.3.1.2 FRANCE 102 13.3.1.3 UK 105 13.3.1.4 ITALY 108 13.3.1.5 SPAIN 111 13.3.1.6 REST OF WESTERN EUROPE 114 13.3.2 EASTERN EUROPE 117 13.4 ASIA-PACIFIC 121 13.4.1 CHINA 125 13.4.2 JAPAN 127 13.4.3 INDIA 130 13.4.4 AUSTRALIA 133 13.4.5 SOUTH KOREA 136 13.4.6 REST OF ASIA-PACIFIC 139 13.5 MIDDLE EAST & AFRICA 142 13.5.1 MIDDLE EAST 145 13.5.2 AFRICA 148 14 COMPETITIVE LANDSCAPE 14.1 OVERVIEW 151 14.2 COMPETITOR DASHBOARD 152 14.3 MAJOR GROWTH STRATEGY IN THE GLOBAL COMPOUNDING CHEMOTHERAPY MARKET 153 14.4 MARKET SHARE ANALYSIS 153 14.5 COMPETITIVE BENCHMARKING 154 14.6 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL COMPOUNDING CHEMOTHERAPY MARKET 155 14.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 156 14.8 KEY DEVELOPMENTS & GROWTH STRATEGIES 156 14.8.1 ACQUISITION 156 14.8.2 COLLABORATION 156 14.8.3 PARTNERSHIP 157 14.8.4 COLLABORATION 157 15 COMPANY PROFILE 15.1 B. BRAUN MELSUNGEN AG 158 15.1.1 COMPANY OVERVIEW 158 15.1.2 FINANCIAL OVERVIEW 158 15.1.3 PRODUCTS/SERVICES OFFERED 159 15.1.4 KEY DEVELOPMENTS 159 15.1.5 SWOT ANALYSIS 160 15.1.6 KEY STRATEGIES 160 15.2 PFIZER INC. 161 15.2.1 COMPANY OVERVIEW 161 15.2.2 FINANCIAL OVERVIEW 161 15.2.3 PRODUCTS/SERVICES OFFERED 162 15.2.4 KEY DEVELOPMENTS 162 15.2.5 SWOT ANALYSIS 162 15.2.6 KEY STRATEGIES 163 15.3 BAXTER 164 15.3.1 COMPANY OVERVIEW 164 15.3.2 FINANCIAL OVERVIEW 164 15.3.3 PRODUCTS/SERVICES OFFERED 165 15.3.4 KEY DEVELOPMENTS 165 15.3.5 SWOT ANALYSIS 165 15.3.6 KEY STRATEGIES 166 15.4 GRIFOLS, S.A. 167 15.4.1 COMPANY OVERVIEW 167 15.4.2 FINANCIAL OVERVIEW 167 15.4.3 PRODUCTS/SERVICES OFFERED 168 15.4.4 KEY DEVELOPMENTS 168 15.4.5 SWOT ANALYSIS 168 15.4.6 KEY STRATEGIES 169 15.5 THE METRIX COMPANY 170 15.5.1 COMPANY OVERVIEW 170 15.5.2 FINANCIAL OVERVIEW 170 15.5.3 PRODUCTS/SERVICES OFFERED 170 15.5.4 KEY DEVELOPMENTS 170 15.5.5 SWOT ANALYSIS 171 15.5.6 KEY STRATEGIES 171 15.6 ADDED PHARMA 172 15.6.1 COMPANY OVERVIEW 172 15.6.2 FINANCIAL OVERVIEW 172 15.6.3 PRODUCTS/SERVICES OFFERED 172 15.6.4 KEY DEVELOPMENTS 173 15.6.5 SWOT ANALYSIS 173 15.6.6 KEY STRATEGIES 173 15.7 EQUASHIELD 174 15.7.1 COMPANY OVERVIEW 174 15.7.2 FINANCIAL OVERVIEW 174 15.7.3 PRODUCTS/SERVICES OFFERED 174 15.7.4 KEY DEVELOPMENTS 174 15.7.5 SWOT ANALYSIS 175 15.7.6 KEY STRATEGIES 175 15.8 MILLERS PHARMACY 176 15.8.1 COMPANY OVERVIEW 176 15.8.2 FINANCIAL OVERVIEW 176 15.8.3 PRODUCTS/SERVICES OFFERED 176 15.8.4 KEY DEVELOPMENTS 176 15.8.5 SWOT ANALYSIS 177 15.8.6 KEY STRATEGIES 177 15.9 COMECER S.P.A. 178 15.9.1 COMPANY OVERVIEW 178 15.9.2 FINANCIAL OVERVIEW 178 15.9.3 PRODUCTS/SERVICES OFFERED 178 15.9.4 SWOT ANALYSIS 179 15.9.5 KEY STRATEGIES 179 15.10 OMNICELL 180 15.10.1 COMPANY OVERVIEW 180 15.10.2 FINANCIAL OVERVIEW 180 15.10.3 PRODUCTS/SERVICES OFFERED 180 15.10.4 SWOT ANALYSIS 181 15.10.5 KEY STRATEGIES 181 15.11 ICON GROUP 182 15.11.1 COMPANY OVERVIEW 182 15.11.2 FINANCIAL OVERVIEW 182 15.11.3 PRODUCTS/SERVICES OFFERED 182 15.11.4 KEY DEVELOPMENTS 183 15.11.5 SWOT ANALYSIS 184 15.11.6 KEY STRATEGIES 184 15.12 DEDALUS GROUP 185 15.12.1 COMPANY OVERVIEW 185 15.12.2 FINANCIAL OVERVIEW 185 15.12.3 PRODUCTS/SERVICES OFFERED 185 15.12.4 KEY DEVELOPMENTS 185 15.12.5 SWOT ANALYSIS 186 15.12.6 KEY STRATEGIES 186 15.13 ARXIUM 187 15.13.1 COMPANY OVERVIEW 187 15.13.2 FINANCIAL OVERVIEW 187 15.13.3 PRODUCTS/SERVICES OFFERED 187 15.13.4 KEY DEVELOPMENTS 187 15.13.5 SWOT ANALYSIS 188 15.13.6 KEY STRATEGIES 188 15.14 STERILINE S.R.L. 189 15.14.1 COMPANY OVERVIEW 189 15.14.2 FINANCIAL OVERVIEW 189 15.14.3 PRODUCTS/SERVICES OFFERED 189 15.14.4 KEY DEVELOPMENTS 189 15.14.5 SWOT ANALYSIS 190 15.14.6 KEY STRATEGIES 190 15.15 LOCCIONI 191 15.15.1 COMPANY OVERVIEW 191 15.15.2 PRODUCTS/SERVICES OFFERED 191 15.15.3 KEY DEVELOPMENTS 191 15.15.4 SWOT ANALYSIS 192 15.15.5 KEY STRATEGIES 192 16 APPENDIX 16.1 REFERENCES 193 16.2 RELATED REPORTS 193

LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 23 TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 26 TABLE 3 LIST OF POTENTIAL CUSTOMERS FOR GLOBAL COMPOUNDING CHEMOTHERAPY MARKET 42 TABLE 1 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 45 TABLE 2 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR CHEMOTHERAPEUTIC, BY REGION, 2017–2027 (USD MILLION) 46 TABLE 3 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR NON-CHEMOTHERAPEUTICS, BY REGION, 2017–2027 (USD MILLION) 46 TABLE 4 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 48 TABLE 5 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR PHARMACEUTICAL INGREDIENT ALTERATION (PIA), BY REGION, 2017–2027 (USD MILLION) 48 TABLE 6 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR CURRENTLY UNAVAILABLE PHARMACEUTICAL MANUFACTURING, BY REGION, 2017–2027 (USD MILLION) 49 TABLE 7 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR PHARMACEUTICAL DOSAGE ALTERATION, BY REGION, 2017–2027 (USD MILLION) 50 TABLE 8 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 52 TABLE 9 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR GRAVIMETRIC AUTOMATED COMPOUNDING DEVICE, BY REGION, 2017–2027 (USD MILLION) 52 TABLE 10 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR VOLUMETRIC AUTOMATED COMPOUNDING DEVICE, BY REGION, 2017–2027 (USD MILLION) 53 TABLE 11 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 54 TABLE 12 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR STERILE, BY REGION, 2017–2027 (USD MILLION) 55 TABLE 13 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR NON-STERILE, BY REGION, 2017–2027 (USD MILLION) 56 TABLE 14 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 57 TABLE 15 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY REGION, 2017–2027 (USD MILLION) 58 TABLE 16 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 58 TABLE 17 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR WITHOUT ROBOTIC ARMS, BY REGION, 2017–2027 (USD MILLION) 59 TABLE 18 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 60 TABLE 19 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 63 TABLE 20 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2017–2027 (USD MILLION) 63 TABLE 21 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR BLOOD CANCER, BY REGION, 2017–2027 (USD MILLION) 64 TABLE 22 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2017–2027 (USD MILLION) 65 TABLE 23 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2017–2027 (USD MILLION) 66 TABLE 24 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR RESPIRATORY/LUNG CANCER, BY REGION, 2017–2027 (USD MILLION) 66 TABLE 25 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET FOR OTHER CANCER APPLICATIONS, BY REGION, 2017–2027 (USD MILLION) 67 TABLE 26 GLOBAL COMPOUNDING CHEMOTHERAPY MARKET, BY REGION, 2017–2027 (USD MILLION) 68 TABLE 27 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET, BY REGION, 2017–2027 (USD MILLION) 69 TABLE 28 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 70 TABLE 29 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 70 TABLE 30 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 71 TABLE 31 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 71 TABLE 32 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 71 TABLE 33 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 72 TABLE 34 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 72 TABLE 35 AMERICAS COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 72 TABLE 36 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 73 TABLE 37 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 73 TABLE 38 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 74 TABLE 39 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 74 TABLE 40 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 74 TABLE 41 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 75 TABLE 42 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 75 TABLE 43 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 75 TABLE 44 NORTH AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 76 TABLE 45 US COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 76 TABLE 46 US COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 77 TABLE 47 US COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 77 TABLE 48 US COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 78 TABLE 49 US COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 78 TABLE 50 US COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 78 TABLE 51 US COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 79 TABLE 52 US COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 79 TABLE 53 CANADA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 79 TABLE 54 CANADA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 80 TABLE 55 CANADA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 80 TABLE 56 CANADA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 80 TABLE 57 CANADA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 81 TABLE 58 CANADA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 81 TABLE 59 CANADA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 81 TABLE 60 CANADA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 82 TABLE 61 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY COUNTRY/REGION, 2017–2027 (USD MILLION) 82 TABLE 62 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 82 TABLE 63 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 83 TABLE 64 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 83 TABLE 65 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 83 TABLE 66 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 84 TABLE 67 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 84 TABLE 68 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 84 TABLE 69 LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 85 TABLE 70 BRAZIL COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 85 TABLE 71 BRAZIL COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 86 TABLE 72 BRAZIL COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 86 TABLE 73 BRAZIL COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 86 TABLE 74 BRAZIL COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 87 TABLE 75 BRAZIL COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 87 TABLE 76 BRAZIL COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 87 TABLE 77 BRAZIL COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 88 TABLE 78 REST OF LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 88 TABLE 79 REST OF LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 89 TABLE 80 REST OF LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 89 TABLE 81 REST OF LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 89 TABLE 82 REST OF LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 90 TABLE 83 REST OF LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 90 TABLE 84 REST OF LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 90 TABLE 85 REST OF LATIN AMERICA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 91 TABLE 86 EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY REGION, 2017–2027 (USD MILLION) 92 TABLE 87 EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 93 TABLE 88 EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 93 TABLE 89 EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 93 TABLE 90 EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 94 TABLE 91 EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 94 TABLE 92 EUROPE COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 94 TABLE 93 EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 95 TABLE 94 EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 95 TABLE 95 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 96 TABLE 96 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 97 TABLE 97 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 97 TABLE 98 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 97 TABLE 99 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 98 TABLE 100 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 98 TABLE 101 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 98 TABLE 102 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 99 TABLE 103 WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 99 TABLE 104 GERMANY COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 99 TABLE 105 GERMANY COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 100 TABLE 106 GERMANY COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 100 TABLE 107 GERMANY COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 100 TABLE 108 GERMANY COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 101 TABLE 109 GERMANY COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 101 TABLE 110 GERMANY COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 101 TABLE 111 GERMANY COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 102 TABLE 112 FRANCE COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 102 TABLE 113 FRANCE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 103 TABLE 114 FRANCE COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 103 TABLE 115 FRANCE COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 103 TABLE 116 FRANCE COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 104 TABLE 117 FRANCE COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 104 TABLE 118 FRANCE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 104 TABLE 119 FRANCE COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 105 TABLE 120 UK COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 105 TABLE 121 UK COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 106 TABLE 122 UK COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 106 TABLE 123 UK COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 106 TABLE 124 UK COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 107 TABLE 125 UK COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 107 TABLE 126 UK COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 107 TABLE 127 UK COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 108 TABLE 128 ITALY COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 108 TABLE 129 ITALY COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 109 TABLE 130 ITALY COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 109 TABLE 131 ITALY COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 109 TABLE 132 ITALY COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 110 TABLE 133 ITALY COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 110 TABLE 134 ITALY COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 110 TABLE 135 ITALY COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 111 TABLE 136 SPAIN COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 111 TABLE 137 SPAIN COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 112 TABLE 138 SPAIN COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 112 TABLE 139 SPAIN COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 112 TABLE 140 SPAIN COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 113 TABLE 141 SPAIN COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 113 TABLE 142 SPAIN COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 113 TABLE 143 SPAIN COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 114 TABLE 144 REST OF WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 114 TABLE 145 REST OF WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 115 TABLE 146 REST OF WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 115 TABLE 147 REST OF WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 115 TABLE 148 REST OF WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 116 TABLE 149 REST OF WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 116 TABLE 150 REST OF WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 116 TABLE 151 REST OF WESTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 117 TABLE 152 EASTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 117 TABLE 153 EASTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 118 TABLE 154 EASTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 118 TABLE 155 EASTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 118 TABLE 156 EASTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 119 TABLE 157 EASTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 119 TABLE 158 EASTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 119 TABLE 159 EASTERN EUROPE COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 120 TABLE 160 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 121 TABLE 161 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 122 TABLE 162 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 122 TABLE 163 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 123 TABLE 164 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 123 TABLE 165 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 123 TABLE 166 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 124 TABLE 167 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 124 TABLE 168 ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 124 TABLE 169 CHINA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 125 TABLE 170 CHINA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 125 TABLE 171 CHINA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 125 TABLE 172 CHINA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 126 TABLE 173 CHINA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 126 TABLE 174 CHINA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 126 TABLE 175 CHINA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 127 TABLE 176 CHINA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 127 TABLE 177 JAPAN COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 127 TABLE 178 JAPAN COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 128 TABLE 179 JAPAN COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 128 TABLE 180 JAPAN COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 128 TABLE 181 JAPAN COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 129 TABLE 182 JAPAN COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 129 TABLE 183 JAPAN COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 129 TABLE 184 JAPAN COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 130 TABLE 185 INDIA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 130 TABLE 186 INDIA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 131 TABLE 187 INDIA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 131 TABLE 188 INDIA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 131 TABLE 189 INDIA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 132 TABLE 190 INDIA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 132 TABLE 191 INDIA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 132 TABLE 192 INDIA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 133 TABLE 193 AUSTRALIA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 133 TABLE 194 AUSTRALIA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 134 TABLE 195 AUSTRALIA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 134 TABLE 196 AUSTRALIA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 134 TABLE 197 AUSTRALIA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 135 TABLE 198 AUSTRALIA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 135 TABLE 199 AUSTRALIA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 135 TABLE 200 AUSTRALIA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 136 TABLE 201 SOUTH KOREA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 136 TABLE 202 SOUTH KOREA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 137 TABLE 203 SOUTH KOREA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 137 TABLE 204 SOUTH KOREA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 137 TABLE 205 SOUTH KOREA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 138 TABLE 206 SOUTH KOREA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 138 TABLE 207 SOUTH KOREA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 138 TABLE 208 SOUTH KOREA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 139 TABLE 209 REST OF ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 139 TABLE 210 REST OF ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 139 TABLE 211 REST OF ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 140 TABLE 212 REST OF ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 140 TABLE 213 REST OF ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 140 TABLE 214 REST OF ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 141 TABLE 215 REST OF ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 141 TABLE 216 REST OF ASIA-PACIFIC COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 141 TABLE 217 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY REGION, 2017–2027 (USD MILLION) 142 TABLE 218 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 143 TABLE 219 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 143 TABLE 220 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 143 TABLE 221 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 144 TABLE 222 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 144 TABLE 223 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 144 TABLE 224 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 145 TABLE 225 MIDDLE EAST & AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 145 TABLE 226 MIDDLE EAST COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 145 TABLE 227 MIDDLE EAST COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 146 TABLE 228 MIDDLE EAST COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 146 TABLE 229 MIDDLE EAST COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 146 TABLE 230 MIDDLE EAST COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 147 TABLE 231 MIDDLE EAST COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 147 TABLE 232 MIDDLE EAST COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 147 TABLE 233 MIDDLE EAST COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 148 TABLE 234 AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY DOSE, 2017–2027 (USD MILLION) 148 TABLE 235 AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDING TYPE, 2017–2027 (USD MILLION) 148 TABLE 236 AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY DELIVERY METHOD, 2017–2027 (USD MILLION) 149 TABLE 237 AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY STERILITY, 2017–2027 (USD MILLION) 149 TABLE 238 AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY TECHNOLOGY, 2017–2027 (USD MILLION) 149 TABLE 239 AFRICA COMPOUNDING CHEMOTHERAPY MARKET FOR WITH ROBOTIC ARMS, BY TYPE, 2017–2027 (USD MILLION) 150 TABLE 240 AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY COMPOUNDER TYPE, 2017–2027 (USD MILLION) 150 TABLE 241 AFRICA COMPOUNDING CHEMOTHERAPY MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 150 TABLE 242 COMPETITOR DASHBOARD: GLOBAL COMPOUNDING CHEMOTHERAPY MARKET 152 TABLE 243 THE MOST ACTIVE PLAYER IN THE GLOBAL COMPOUNDING CHEMOTHERAPY MARKET 155 TABLE 244 ACQUISITION 156 TABLE 245 COLLABORATION 156 TABLE 246 PARTNERSHIP 157 TABLE 247 COLLABORATION 157 TABLE 248 B BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED 159 TABLE 249 PFIZER INC.: PRODUCTS/SERVICES OFFERED 162 TABLE 250 BAXTER: PRODUCTS/SERVICES OFFERED 165 TABLE 251 GRIFOLS, S.A.: PRODUCTS/SERVICES OFFERED 168 TABLE 252 THE METRIX COMPANY PRODUCTS/SERVICES OFFERED 170 TABLE 253 ADDED PHARMA: PRODUCTS/SERVICES OFFERED 172 TABLE 254 EQUASHILED: PRODUCTS/SERVICES OFFERED 174 TABLE 255 EQUASHIELD: KEY DEVELOPMENTS 174 TABLE 256 MILLERS PHARMACY: PRODUCTS/SERVICES OFFERED 176 TABLE 257 COMECER S.P.A.: PRODUCTS/SERVICES OFFERED 178 TABLE 258 KEY DEVELOPMENTS 178 TABLE 259 OMNICELL.: PRODUCTS/SERVICES OFFERED 180 TABLE 260 KEY DEVELOPMENTS 181 TABLE 261 ICON GROUP: PRODUCTS/SERVICES OFFERED 182 TABLE 262 ICON GROUP: KEY DEVELOPMENTS 183 TABLE 263 DEDALUS GROUP: PRODUCTS/SERVICES OFFERED 185 TABLE 264 DEDALUS GROUP: KEY DEVELOPMENTS 185 TABLE 265 ARXIUM: PRODUCTS/SERVICES OFFERED 187 TABLE 266 STERILINE S.R.L.: PRODUCTS/SERVICES OFFERED 189 TABLE 267 LOCCIONI: PRODUCTS/SERVICES OFFERED 191

Braun Melsungen AG, Pfizer Inc., Baxter, Grifols SA, The Metrix Company, Added Pharma, Equashield, Millers Pharmacy, Comecer S.P.A., Omnicell, Icon group, Dedalus Group, Arxium, Sterline S.R.L., and Loccioni